Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 CAD | +13.51% | +1.20% | +20.00% |
Apr. 10 | Avicanna Inc. Announces Completion of Topical Gel Observational Real-World Evidence Study | CI |
Apr. 02 | Transcript : Avicanna Inc., 2023 Earnings Call, Apr 02, 2024 |
Chart calendar Avicanna Inc.
Upcoming events on Avicanna Inc.
Past events on Avicanna Inc.
2024-04-02 08:30 am | Q4 2023 Earnings Call |
2024-04-01 09:03 pm | Q4 2023 Earnings Release |
2023-11-15 08:30 am | Q3 2023 Earnings Call |
2023-11-14 05:00 pm | Q3 2023 Earnings Release |
2023-08-14 05:07 pm | Q2 2023 Earnings Release |
2023-06-28 12:00 pm | Business Update Call |
2023-05-17 10:30 am | Annual General Meeting |
2023-05-15 06:59 pm | Q1 2023 Earnings Release |
2023-03-31 07:58 pm | Q4 2022 Earnings Release |
2023-03-27 12:00 am | Investor Meeting |
2022-11-11 07:30 am | Q3 2022 Earnings Release |
2022-08-31 10:30 am | Annual General Meeting |
2022-08-15 05:00 pm | Interim 2022 Earnings Release |
2022-06-22 10:30 am | Emerging Growth Conference |
2022-05-12 08:54 pm | Q1 2022 Earnings Release |
2022-03-31 08:50 pm | FY 2021 Earnings Release |
2022-02-03 11:00 am | FY 2021 Guidance Call |
2021-12-13 11:00 am | Lytham Partners Winter Investor Conference |
2021-11-12 08:30 am | Q3 2021 Earnings Call |
2021-11-12 07:30 am | Q3 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 0,17 0,50 -66.35% | 0,00 | 3,27 3,10 5.45% |
EBITDA Million CAD | Released Forecast Spread | -22,3 -15,0 -48.67% | 0,00 | -9,04 -9,40 3.85% |
EBIT Million CAD | Released Forecast Spread | -23,2 -18,3 -26.9% | 0,00 | -9,93 -11,1 10.52% |
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -23,2 -17,9 -29.87% | 0,00 | -16,8 -11,1 -51% |
Net income Million CAD | Released Forecast Spread | -21,1 -17,7 -19.05% | -32,9 | -16,8 -10,9 -53.89% |
EPS CAD | Released Forecast Spread | -1,16 -0,91 -27.47% | -1,18 | -0,47 -0,26 -80.77% |
Announcement Date | 15/04/20 | 03/09/21 | 31/03/22 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 |
---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 1,22 1,10 10.71% | 1,04 1,70 -38.94% |
EBITDA Million CAD | Released Forecast Spread | -2,06 -2,10 1.94% | -0,40 -1,60 75.11% |
EBIT Million CAD | Released Forecast Spread | -2,29 -2,50 8.49% | -0,65 -2,10 68.97% |
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -8,22 -2,50 -228.71% | -0,94 -2,10 55.28% |
Net income Million CAD | Released Forecast Spread | -8,23 -2,50 -229.26% | -0,94 -2,10 55.28% |
EPS CAD | Released Forecast Spread | -0,18 -0,06 -200% | -0,02 -0,05 59.14% |
Announcement Date | 31/03/22 | 12/05/22 |
Past sector events for Avicanna Inc.
2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
2024-03-27 10:25 am | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVCN Stock
- Calendar Avicanna Inc.